组织工程与再生医学：技术与全球市场

全球组织工程和再生医学市场预计将从 2024 年的 48 亿美元和 2025 年的 54 亿美元成长到 2030 年的 98 亿美元，2025 年至 2030 年的复合年增长率为 12.8%。

预计北美市场规模将从2024年的21亿美元和2025年的24亿美元成长到2030年的45亿美元，预测期内复合年增长率为13.3%。预计亚太市场规模将从2024年的8.884亿美元成长到2025年的10亿美元，复合年增长率为15.5%，到2030年将达到21亿美元。

本报告研究了全球组织工程和再生医学市场，并提供了市场概况、市场影响因素和市场机会分析、市场规模趋势和预测以及各个细分市场和地区的详细分析。

目录

第一章执行摘要

• 市场展望
• 调查范围
• 市场摘要

第二章 市场概述

• 概述
• 波特五力分析
• 宏观经济因素分析
• 人口老化
• 法规环境
• 政府政策与合作
• 美国关税情景

第三章 市场动态

• 市场动态
• 市场驱动因素
• 再生医学的需求不断增长
• 增加组织工程研究和核准
• 增加创业投资资金筹措
• 市场限制
• 治疗费用高昂
• 复杂的控制途径
• 市场机会
• 技术进步
• 新兴经济体

第四章：监理现状

• 美国
• 欧洲
• 亚太地区

第五章人工智慧应用对组织工程和再生医学市场的影响

• 概述
• 案例研究
• 问题
• 解决方案
• 结果
• 人工智慧采用趋势
• 北美的采用趋势
• 欧洲采用趋势
• 其他地区的采用趋势
• 人工智慧带来的颠覆性变化趋势
• 人工智慧对价值链各阶段的影响
• 市场支出和投资情景
• 人工智慧领域的创投

第六章 新兴科技与发展

• 新兴技术
• 3D生物列印
• 器官晶片
• 智慧生医材料
• AI
• 临床试验分析
• 关键要点
• 按研究类型进行的临床试验分析
• 临床试验分析：按状态
• 临床试验分析：按阶段
• 专利分析
• 关键要点
• 专利：按年份
• 主要申请人的专利
• 顶级所有者的专利
• 专利：依管辖范围

第七章市场区隔分析

• 细分市场
• 按产品类型进行市场分析
• 关键要点
• 鹰架
• 生物来源支架
• 合成支架
• 接枝
• 同种异体移植
• 自体移植
• 合成移植物
• 异质骨移植
• 市场分析：按材料
• 关键要点
• 生物来源材料
• 合成材料
• 市场分析：按应用
• 关键要点
• 整形外科和肌肉骨骼疾病
• 皮肤病学和创伤护理
• 牙科疾病
• 心血管疾病
• 其他的
• 地理分布
• 各地区市场分析
• 关键要点
• 北美洲
• 欧洲
• 亚太地区
• 中东和非洲
• 南美洲

第八章 竞争讯息

• 关键要点
• 竞争格局
• 主要企业全球市场占有率
• 关键发展和策略

第九章 组织工程与再生医学的永续性：ESG 视角

• ESG：简介
• 组织工程与再生医学的永续性：ESG视角
• 关键 ESG 议题
• 组织工程与再生医学：ESG绩效分析
• BCC的结论

第十章 附录

• 调查方法
• 来源
• 简称
• 公司简介
• ABBVIE INC.
• ALICORN MEDICAL PVT. LTD.
• BAXTER
• B. BRAUN SE
• BD
• BIOTISSUE
• INTEGRA LIFESCIENCES
• JOHNSON & JOHNSON SERVICES INC.
• MEDTRONIC
• MIMEDX GROUP INC.
• ORGANOGENESIS INC.
• SMITH+NEPHEW
• STRYKER
• TECNOSS
• ZIMMER BIOMET
• 新兴Start-Ups/市场颠覆者

The global market for tissue engineering and regeneration was valued at $4.8 billion in 2024 and is estimated to increase from $5.4 billion in 2025 to reach $9.8 billion by 2030, at a compound annual growth rate (CAGR) of 12.8% from 2025 through 2030.

The North American market for tissue engineering and regeneration was valued at $2.1 billion in 2024 and is estimated to increase from $2.4 billion in 2025 to reach $4.5 billion by 2030, at a CAGR of 13.3% from 2025 through 2030.

The Asia-Pacific market for tissue engineering and regeneration was valued at $888.4 million in 2024 and is estimated to increase from $1 billion in 2025 to reach $2.1 billion by 2030, at a CAGR of 15.5% from 2025 through 2030.

Report Scope

The report provides an overview of the global tissue engineering and regeneration market and analyzes market trends. It includes global revenue ($ million) using 2024 as the base year, estimated data for 2025, and projected data for 2026 through 2030.

The market is segmented into product type, material, and application. By product, the market is categorized into scaffolds and tissue grafts. By material, the market is segmented into biologically derived materials and synthetic materials. Based on application, the market is segmented into orthopedic and musculoskeletal disorders, dermatology and wound care, dental disorders, cardiovascular diseases, and others. Geographical regions covered in this study are North America (the U.S., Canada, and Mexico), Europe (Germany, the U.K., Italy, France, and the Rest of Europe), Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific), the Middle East and Africa (MEA), and South America, focusing on all the major countries in these regions.

The report focuses on the significant driving trends and challenges that affect the market and vendor landscape. It analyzes environmental, social and corporate governance (ESG) developments and discusses emerging technologies related to the market.

The report concludes by analyzing the competitive landscape and providing the ranking/share of key global tissue engineering and regeneration companies. It also contains a dedicated section of company profiles that covers details such as overview, key financials, product portfolio and recent developments in major companies.

Report Includes

• 47 data tables and 64 additional tables
• Analyses of the trends in global markets for tissue engineering and regeneration technologies, with historic revenue data from 2022 to 2024, estimates for 2025, and projected CAGRs through 2030
• Estimates of the market's size and revenue prospects, accompanied by a market share analysis by product type, material, application and region
• Facts and figures pertaining to market dynamics, technological advances, regulations and the impact of macroeconomic factors
• Insights derived from Porter's Five Forces model, as well as global supply chain analysis
• Patent analysis, featuring key granted and published patents
• Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, as well as the ESG risk ratings and practices of leading companies
• Analysis of the industry structure, including companies' market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
• Company profiles of major players within the industry, including Organogenesis Inc., Integra LifeSciences, Smith+Nephew, MiMedx Group Inc., and Johnson & Johnson Services Inc.

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Overview
• Porter's Five Forces Analysis in the Tissue Engineering and Regeneration Market
• Potential for New Entrants (Moderate to High)
• Bargaining Power of Suppliers (Moderate to High)
• Bargaining Power of Buyers (High)
• Threat of Substitutes (Low to Moderate)
• Competition in the Industry (High)
• Macroeconomic Factor Analysis
• Aging Population
• Regulatory Environment
• Government Policy and Collaboration
• The U.S. Tariff Scenario

Chapter 3 Market Dynamics

• Market Dynamics
• Market Drivers
• Rising Demand for Regenerative Medicine
• Growing Research and Approvals in Tissue Engineering
• Increasing Venture Capital Funding
• Market Restraints
• High Cost Associated with Treatment
• Complex Regulatory Pathway
• Market Opportunities
• Technological Advances
• Emerging Economies

Chapter 4 Regulatory Landscape

• The U.S.
• Europe
• Asia-Pacific

Chapter 5 Impact of AI Adoption on the Tissue Engineering and Regeneration Market

• Overview
• Case Studies
• Problem
• Solution
• Outcome
• AI Adoption: Trends
• Adoption Trends in North America
• Adoption Trends in Europe
• Adoption Trends in the Rest of the World
• AI Disruption Trends
• Impact of AI on Various Stages of the Value Chain
• Market Spending and Investment Scenario
• VC Investment in AI

Chapter 6 Emerging Technologies and Developments

• Emerging Technologies
• 3D Bioprinting
• Organ-on-a-Chip
• Smart Biomaterial
• Artificial Intelligence
• Clinical Trials Analysis
• Key Takeaways
• Clinical Trials Analysis, by Type of Study
• Clinical Trials Analysis, by Status
• Clinical Trials Analysis, by Phase
• Patent Analysis
• Key Takeaways
• Patents, by Year
• Patents by Top Applicant
• Patents by Top Owner
• Patents by Jurisdiction

Chapter 7 Market Segmentation Analysis

• Segmentation Breakdown
• Market Analysis by Product Type
• Key Takeaways
• Scaffolds
• Biological Scaffolds
• Synthetic Scaffolds
• Grafts
• Allogenic
• Autogenic
• Synthetic
• Xenogeneic
• Market Analysis by Material
• Key Takeaways
• Biologically Derived Material
• Synthetic Material
• Market Analysis by Application
• Key Takeaways
• Orthopedics and Musculoskeletal Disorders
• Dermatology and Wound Care
• Dental Disorders
• Cardiovascular Diseases
• Others
• Geographic Breakdown
• Market Analysis by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• Middle East and Africa (MEA)
• South America

Chapter 8 Competitive Intelligence

• Key Takeaways
• Competitive Landscape
• Global Market Shares of Leading Companies
• Key Developments and Strategies

Chapter 9 Sustainability in Tissue Engineering and Regeneration: An ESG Perspective

• Introduction to ESG
• Sustainability in Tissue Engineering and Regeneration: An ESG Perspective
• Key ESG Issues
• Tissue Engineering and Regeneration ESG Performance Analysis
• Concluding Remarks from BCC

Chapter 10 Appendix

• Methodology
• Sources
• Abbreviations
• Company Profiles
• ABBVIE INC.
• ALICORN MEDICAL PVT. LTD.
• BAXTER
• B. BRAUN SE
• BD
• BIOTISSUE
• INTEGRA LIFESCIENCES
• JOHNSON & JOHNSON SERVICES INC.
• MEDTRONIC
• MIMEDX GROUP INC.
• ORGANOGENESIS INC.
• SMITH+NEPHEW
• STRYKER
• TECNOSS
• ZIMMER BIOMET
• A Few Emerging Start-ups/Market Disruptors

List of Tables

• Summary Table : Global Market for Tissue Engineering and Regeneration, by Region, Through 2030
• Table 1 : Porter's Five Forces Analysis: Overview
• Table 2 : Tissue Engineering and Regeneration: Venture Capital Funding, 2024
• Table 3 : Tissue Engineering & Regeneration: Pricing
• Table 4 : Tissue Engineering and Regeneration: Regulatory Overview, 2025
• Table 5 : Asia-Pacific: Regulatory Landscape, 2024
• Table 6 : Clinical Trials in Tissue Engineering, by Type of Study, June 2025
• Table 7 : Clinical Trials in Tissue Engineering, by Status, June 2025
• Table 8 : Clinical Trials in Tissue Engineering, by Phase, June 2025
• Table 9 : Patents, by Top Applicant, 2021-2024
• Table 10 : Patents, by Top Owner, 2021-2024
• Table 11 : Patents, by Jurisdiction, 2021-2024
• Table 12 : Global Market for Tissue Engineering and Regeneration, by Product Type, Through 2030
• Table 13 : Comparison of Extracellular Matrix Functions and Scaffold Analogs in Tissue Engineering
• Table 14 : Global Market for Scaffolds in Tissue Engineering and Regeneration, by Type, Through 2030
• Table 15 : Biological Scaffold Materials: Advantages and Disadvantages
• Table 16 : Synthetic Scaffold Materials: Advantages and Disadvantages
• Table 17 : Global Market for Grafts in Tissue Engineering and Regeneration, by Source, Through 2030
• Table 18 : List of Bioengineered Autogenic Grafts
• Table 19 : Global Market for Tissue Engineering and Regeneration, by Material, Through 2030
• Table 20 : Tissue Engineering and Regeneration: Biomaterial
• Table 21 : Global Market for Tissue Engineering and Regeneration, by Application, Through 2030
• Table 22 : Orthopedics and Musculoskeletal Disorders: Tissue Engineering and Regeneration Product
• Table 23 : Dermatology and Wound Care: Tissue Engineering and Regeneration Products
• Table 24 : Global Market for Tissue Engineering and Regeneration, by Region, Through 2030
• Table 25 : North American Market for Tissue Engineering and Regeneration, by Country, Through 2030
• Table 26 : North American Market for Tissue Engineering and Regeneration, by Product Type, Through 2030
• Table 27 : North American Market for Scaffolds in Tissue Engineering and Regeneration, by Type, Through 2030
• Table 28 : North American Market for Grafts in Tissue Engineering and Regeneration, by Source, Through 2030
• Table 29 : North American Market for Tissue Engineering and Regeneration, by Material, Through 2030
• Table 30 : North American Market for Tissue Engineering and Regeneration, by Application, Through 2030
• Table 31 : European Market for Tissue Engineering and Regeneration, by Country, Through 2030
• Table 32 : European Market for Tissue Engineering and Regeneration, by Product Type, Through 2030
• Table 33 : European Market for Scaffolds in Tissue Engineering and Regeneration, by Type, Through 2030
• Table 34 : European Market for Grafts in Tissue Engineering and Regeneration, by Source, Through 2030
• Table 35 : European Market for Tissue Engineering and Regeneration, by Material, Through 2030
• Table 36 : European Market for Tissue Engineering and Regeneration, by Application, Through 2030
• Table 37 : Asia-Pacific Market for Tissue Engineering and Regeneration, by Country, Through 2030
• Table 38 : Asia-Pacific Market for Tissue Engineering and Regeneration, by Product Type, Through 2030
• Table 39 : Asia-Pacific Market for Scaffolds in Tissue Engineering and Regeneration, by Type, Through 2030
• Table 40 : Asia-Pacific Market for Graft in Tissue Engineering and Regeneration, by Source, Through 2030
• Table 41 : Asia-Pacific Market for Tissue Engineering and Regeneration, by Material, Through 2030
• Table 42 : Asia-Pacific Market for Tissue Engineering and Regeneration, by Application, Through 2030
• Table 43 : MEA Market for Tissue Engineering and Regeneration, by Product Type, Through 2030
• Table 44 : MEA Market for Scaffolds in Tissue Engineering and Regeneration, by Type, Through 2030
• Table 45 : MEA Market for Graft in Tissue Engineering and Regeneration, by Source, Through 2030
• Table 46 : MEA Market for Tissue Engineering and Regeneration, by Material, Through 2030
• Table 47 : MEA Market for Tissue Engineering and Regeneration, by Application, Through 2030
• Table 48 : South American Market for Tissue Engineering and Regeneration, by Product Type, Through 2030
• Table 49 : South American Market for Scaffolds in Tissue Engineering and Regeneration, by Type, Through 2030
• Table 50 : South American Market for Graft in Tissue Engineering and Regeneration, by Source, Through 2030
• Table 51 : South American Market for Tissue Engineering and Regeneration, by Material, Through 2030
• Table 52 : South American Market for Tissue Engineering and Regeneration, by Application, Through 2030
• Table 53 : Top 5 Leading Manufacturers of Tissue Engineering and Regeneration Market, 2024
• Table 54 : Tissue Engineering and Regeneration: Recent Strategic Developments, 2022-2025
• Table 55 : ESG Rankings in Tissue Engineering and Regeneration Companies, 2025*
• Table 56 : ESG: Environmental Overview
• Table 57 : ESG: Social Overview
• Table 58 : ESG: Governance Overview
• Table 59 : Report Information Sources
• Table 60 : Abbreviations Used in the Global Tissue Engineering and Regeneration Market Report
• Table 61 : AbbVie Inc.: Company Snapshot
• Table 62 : AbbVie Inc.: Financial Performance, FY 2023 and 2024
• Table 63 : AbbVie Inc.: Product Portfolio
• Table 64 : AbbVie Inc.: News/Key Developments, 2023
• Table 65 : Alicorn Medical Pvt. Ltd.: Company Snapshot
• Table 66 : Alicorn Medical Pvt. Ltd.: Product Portfolio
• Table 67 : Alicorn Medical Pvt. Ltd.: News/Key Developments, 2025
• Table 68 : Baxter: Company Snapshot
• Table 69 : Baxter: Financial Performance, FY 2023 and 2024
• Table 70 : Baxter: Product Portfolio
• Table 71 : B. Braun SE: Company Snapshot
• Table 72 : B. Braun SE: Financial Performance, FY 2023 and 2024
• Table 73 : B. Braun SE: Product Portfolio
• Table 74 : BD: Company Snapshot
• Table 75 : BD: Financial Performance, FY 2023 and 2024
• Table 76 : BD: Product Portfolio
• Table 77 : BD: News/Key Developments, 2025
• Table 78 : BioTissue: Company Snapshot
• Table 79 : BioTissue: Product Portfolio
• Table 80 : BioTissue: News/Key Developments, 2022 and 2024
• Table 81 : Integra LifeSciences: Company Snapshot
• Table 82 : Integra LifeSciences: Financial Performance, FY 2023 and 2024
• Table 83 : Integra LifeSciences: Product Portfolio
• Table 84 : Integra LifeSciences: News/Key Developments, 2022
• Table 85 : Johnson & Johnson Services Inc.: Company Snapshot
• Table 86 : Johnson & Johnson Services Inc.: Financial Performance, FY 2023 and 2024
• Table 87 : Johnson & Johnson Services Inc.: Product Portfolio
• Table 88 : Medtronic: Company Snapshot
• Table 89 : Medtronic: Financial Performance, FY 2023 and 2024
• Table 90 : Medtronic: Product Portfolio
• Table 91 : MIMEDX Group Inc.: Company Snapshot
• Table 92 : MIMEDX Group Inc.: Financial Performance, FY 2023 and 2024
• Table 93 : MIMEDX Group Inc.: Product Portfolio
• Table 94 : MIMEDX Group Inc.: News/Key Developments, 2022-2024
• Table 95 : Organogenesis Inc.: Company Snapshot
• Table 96 : Organogenesis Inc.: Financial Performance, FY 2023 and 2024
• Table 97 : Organogenesis Inc.: Product Portfolio
• Table 98 : Smith+Nephew: Company Snapshot
• Table 99 : Smith+Nephew: Financial Performance, FY 2023 and 2024
• Table 100 : Smith+Nephew: Product Portfolio
• Table 101 : Smith+Nephew: News/Key Developments, 2023 and 2024
• Table 102 : Stryker: Company Snapshot
• Table 103 : Stryker: Financial Performance, FY 2023 and 2024
• Table 104 : Stryker: Product Portfolio
• Table 105 : Tecnoss: Company Snapshot
• Table 106 : Tecnoss: Product Portfolio
• Table 107 : Zimmer Biomet: Company Snapshot
• Table 108 : Zimmer Biomet: Financial Performance, FY 2023 and 2024
• Table 109 : Zimmer Biomet: Product Portfolio
• Table 110 : List of a Few Emerging Start-ups/ Market Disruptors

List of Figures

• Summary Figure : Global Market Shares of Tissue Engineering and Regeneration, by Region, 2024
• Figure 1 : Tissue Engineering: Triad
• Figure 2 : Porter's Five Forces Analysis of the Tissue Engineering and Regeneration Market
• Figure 3 : Market Dynamics of Tissue Engineering and Regeneration
• Figure 4 : Number of Publications, by Year, 2021-2024
• Figure 5 : AI in Tissue Engineering
• Figure 6 : AI: Global Leaders, Ranking, 2025
• Figure 7 : Impact of AI on Key Industry Verticals
• Figure 8 : Impact of AI on Value Chain
• Figure 9 : Emerging Trends/Technologies in the Tissue Engineering and Regeneration Market
• Figure 10 : Patents Granted, by Year, 2021-2024
• Figure 11 : Global Market Shares of Tissue Engineering and Regeneration, by Product Type, 2024
• Figure 12 : Global Market Shares of Scaffolds in Tissue Engineering and Regeneration, by Type, 2024
• Figure 13 : Global Market Shares of Grafts in Tissue Engineering and Regeneration, by Source, 2024
• Figure 14 : Global Market Shares of Tissue Engineering and Regeneration, by Material, 2024
• Figure 15 : Global Market Shares of Tissue Engineering and Regeneration, by Application, 2024
• Figure 16 : Global Market Shares of Tissue Engineering and Regeneration, by Region, 2024
• Figure 17 : North American Market Shares of Tissue Engineering and Regeneration, by Country, 2024
• Figure 18 : European Market Shares of Tissue Engineering and Regeneration, by Country, 2024
• Figure 19 : Asia-Pacific Market Shares of Tissue Engineering and Regeneration, by Country, 2024
• Figure 20 : Company Share Analysis of Tissue Engineering and Regeneration Market, 2024
• Figure 21 : ESG Pillars
• Figure 22 : Advantages of ESG for Companies
• Figure 23 : AbbVie Inc.: Revenue Shares, by Business Unit, FY 2024
• Figure 24 : AbbVie Inc.: Revenue Shares, by Country/Region, FY 2024
• Figure 25 : Baxter: Revenue Shares, by Business Unit, FY 2024
• Figure 26 : Baxter: Revenue Shares, by Country/Region, FY 2024
• Figure 27 : B. Braun SE: Revenue Shares, by Business Unit, FY 2024
• Figure 28 : B. Braun SE: Revenue Shares, by Country/Region, FY 2024
• Figure 29 : BD: Revenue Shares, by Business Unit, FY 2024
• Figure 30 : BD: Revenue Shares, by Country/Region, FY 2024
• Figure 31 : Integra LifeSciences: Revenue Shares, by Business Segment, FY 2024
• Figure 32 : Integra LifeSciences: Revenue Shares, by Country/Region, FY 2024
• Figure 33 : Johnson & Johnson Services Inc.: Revenue Shares, by Business Segment, FY 2024
• Figure 34 : Johnson & Johnson Services Inc.: Revenue Shares, by Country/Region, FY 2024
• Figure 35 : Medtronic: Revenue Shares, by Business Segment, FY 2024
• Figure 36 : Medtronic: Revenue Shares, by Country/Region, FY 2024
• Figure 37 : MIMEDX Group Inc.: Revenue Shares, by Business Segment, FY 2024
• Figure 38 : Organogenesis Inc.: Revenue Shares, by Business Segment, FY 2024
• Figure 39 : Smith+Nephew: Revenue Shares, by Business Segment, FY 2024
• Figure 40 : Smith+Nephew: Revenue Shares, by Country/Region, FY 2024
• Figure 41 : Stryker: Revenue Shares, by Business Segment, FY 2024
• Figure 42 : Stryker: Revenue Shares, by Country/Region, FY 2024
• Figure 43 : Zimmer Biomet: Revenue Shares, by Business Segment, FY 2024
• Figure 44 : Zimmer Biomet: Revenue Shares, by Country/Region, FY 2024